FPMAJ’s NHI Drug Price Study Committee to Set Up Task Forces for Long-Listed Products, Cost Effectiveness

    June 11, 2012
    The Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) NHI Drug Price Study Committee revealed at a news conference held on June 8 that in preparation for discussions at the Central Social Insurance Medical Council (CSIMC) on the NHI pricing...read more